This article highlights recent developments in healthcare, including the U.S. FDA's approval of Alzheimer's and diabetes ...

Continuous glucose monitors like Dexcom's Stelo and Abbott's Lingo are small, wearable devices that track blood glucose ...

The company estimates that its install base surpassed 15,000 by the end of last year, leading to sales of more than $20 ...

Ozempic and Wegovy do the same thing as GLP-1 would normally do for you — but to enable them to treat diabetes and obesity, ...

A provision about insulin in the Inflation Reduction Act is conflated with a 2022 executive order by former President Joe ...

The FDA has approved Ozempic to reduce kidney failure risk in people with type 2 diabetes and chronic kidney disease. Studies ...

DURHAM, N.C.and SEATTLE, Jan. 28, 2025 (GLOBE NEWSWIRE) -- . (Nasdaq: HUMA), a commercial-stage biotechnology platform company developing universally implantable, bioengineered human tissue at ...

“Rescinding the cap on insulin at $35 only makes pharmaceutical richer and everyday Americans, including MAGA voters, seriously poorer,” Steven Bechloss—author of the Substack, America, America — ...

A new formulation for medicine that does not need cold chain support, new air cargo friendly ultra-cold storage, and the FDA ...

While some studies suggest probiotics may help you lose weight and belly fat, more research is needed on their effectiveness.

Beta Bionics, Inc. (BBNX) is planning to raise $112 million in an initial public offering on Thursday, January 30th, IPO Scoop reports. The company will be issuing 7,500,000 shares at $14.00-$16.00 ...